Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person FGFR2c S252W [plasma membrane]

Class:IdEntityWithAccessionedSequence:2011852
_displayNameFGFR2c S252W [plasma membrane]
_timestamp2014-11-20 17:27:45
compartment[Compartment:876] plasma membrane
created[InstanceEdit:2011853] Rothfels, K, 2011-11-22
crossReference[DatabaseIdentifier:2023337] COSMIC:COSM41289
[DatabaseIdentifier:2023336] COSMIC:COSV60638319
disease[Disease:2011822] acrocephalosyndactylia
[Disease:2011847] craniosynostosis
[Disease:1614674] female reproductive endometrioid cancer
[Disease:1500575] ovarian cancer
[Disease:1500689] cancer
[Disease:2032940] bone development disease
endCoordinate821
hasModifiedResidue[ReplacedResidue:2033281] L-serine 252 replaced with L-tryptophan
literatureReference[LiteratureReference:1637882] Drug-sensitive FGFR2 mutations in endometrial carcinoma
[LiteratureReference:1637876] Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
[LiteratureReference:2011820] Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity
[LiteratureReference:2029807] FGFR2 mutations are rare across histologic subtypes of ovarian cancer
modified[InstanceEdit:2023368] Rothfels, K, 2011-12-07
[InstanceEdit:2029894] Rothfels, K, 2012-01-05
[InstanceEdit:2033280] Rothfels, K, 2012-01-09
[InstanceEdit:3612887] Jupe, S, 2013-05-23
[InstanceEdit:5649555] Rothfels, Karen, 2014-11-20
nameFGFR2c S252W
FGFR2-1 S252W mutant
referenceEntity[ReferenceIsoform:54816] UniProt:P21802-1 FGFR2 [Homo sapiens]
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:2298497] R-HSA-2011852.1
startCoordinate22
summation[Summation:1637914] also Apert
(hasComponent)[Complex:2011938] FGFR2c S252W mutant dimer [plasma membrane] [Homo sapiens]
(hasMember)[CandidateSet:2033375] FGFR2c mutants with enhanced ligand binding [plasma membrane] [Homo sapiens]
(updatedInstance)[_UpdateTracker:9884377] Update Tracker - [EntityWithAccessionedSequence:2011852] FGFR2c S252W [plasma membrane] - v45:[addName]
[_UpdateTracker:9891052] Update Tracker - [EntityWithAccessionedSequence:2011852] FGFR2c S252W [plasma membrane] - v52:[modifyName]
[Change default viewing format]
No pathways have been reviewed or authored by FGFR2c S252W [plasma membrane] (2011852)